The company's flagship product, CUE1, is a wearable device that uses vibrotactile stimulation to modulate sensory dysfunction in Parkinson's patients, resulting in improved movement speed and coordination. The device has shown promising results in pilot studies, with participants reporting smoother and better-coordinated movement. With over 10 million people worldwide suffering from Parkinson's, Charco Neurotech's innovative technology has the potential to significantly improve the lives of many.